Hexymelt 2mg Tablet MD contains Trihexyphenidyl 2mg, an anticholinergic agent primarily used in the management of Parkinson’s disease and extrapyramidal symptoms induced by antipsychotic medications. Trihexyphenidyl acts by blocking central cholinergic receptors, thereby restoring the balance between dopamine and acetylcholine in the central nervous system. This mechanism helps alleviate symptoms such as muscle rigidity, tremors, and bradykinesia associated with Parkinsonism. Hexymelt 2mg is indicated for the treatment of idiopathic Parkinson’s disease, drug-induced extrapyramidal reactions, and other movement disorders characterized by cholinergic-dopaminergic imbalance. The tablet is designed for oral administration and should be taken as prescribed by a healthcare professional. Dosage adjustments may be necessary based on clinical response and tolerability. Common side effects include dry mouth, blurred vision, constipation, urinary retention, and dizziness, which are related to its anticholinergic properties. Caution is advised in patients with glaucoma, prostatic hypertrophy, or gastrointestinal obstruction. Hexymelt 2mg should be used under medical supervision, with careful monitoring for adverse effects and therapeutic efficacy. It is contraindicated in individuals with hypersensitivity to trihexyphenidyl or other anticholinergic agents.